New York State Common Retirement Fund boosted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,598,820 shares of the pharmacy operator’s stock after buying an additional 194,732 shares during the quarter. New York State Common Retirement Fund owned about 0.24% of Walgreens Boots Alliance worth $203,514,000 at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of the business. Hudock Capital Group LLC boosted its holdings in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares during the period. Reilly Financial Advisors LLC boosted its holdings in Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after acquiring an additional 100 shares during the period. Orrstown Financial Services Inc. boosted its holdings in Walgreens Boots Alliance by 14.1% during the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after acquiring an additional 213 shares during the period. Founders Capital Management bought a new stake in Walgreens Boots Alliance during the first quarter valued at about $161,000. Finally, Hanson McClain Inc. boosted its holdings in Walgreens Boots Alliance by 4.6% during the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock valued at $156,000 after acquiring an additional 87 shares during the period. 63.58% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director John Anthony Lederer purchased 20,000 shares of the stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 13.50% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Stock Observer and is owned by of Stock Observer. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.thestockobserver.com/2017/11/15/new-york-state-common-retirement-fund-has-203-51-million-holdings-in-walgreens-boots-alliance-inc-wba.html.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at $70.59 on Wednesday. The firm has a market cap of $71,041.97, a P/E ratio of 13.80, a PEG ratio of 1.25 and a beta of 1.20. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance, Inc. has a fifty-two week low of $63.82 and a fifty-two week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business posted $1.07 earnings per share. equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 42.33%.
Walgreens Boots Alliance announced that its Board of Directors has authorized a share repurchase plan on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.
Several equities research analysts recently weighed in on the stock. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. Loop Capital assumed coverage on shares of Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 target price for the company. UBS AG reiterated a “buy” rating and issued a $96.00 target price (down previously from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Finally, Mizuho set a $94.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, October 24th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $87.63.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.